Merck Millipore, the Life Science business of Merck, has partnered with celares GmbH to provide pegylation services tocustomers developing protein-based therapeutics and biosimilars. The new service offering under the collaboration includes feasibility studies, process and analyticaldevelopment, and scale-up from milligram to gram quantities required for pilot and subsequent commercial scale. Pegylation, the attachment of polyethylene glycol to a molecule, is a delivery system for biologics t...